About Us

Headquartered in Texas, MicroTransponder Inc. has developed the Paired Vagus Nerve Stimulation Platform (Paired VNS™ Platform), based on decades of neuroscience research. The Vivistim® System, for treatment of post-stroke upper limb mobility issues, is the first FDA-approved system on the platform. MicroTransponder is researching ways to expand the Paired VNS™ platform to help patients with other chronic neurologic conditions.

Management Team


Richard Foust

Richard Foust

CEO

Richard is an entrepreneur and investor with over 20 years of global commercial leadership experience in the healthcare industry.  He has expertise in building organizations to successfully execute GTM strategies with medical devices and digital health platforms. Richard previously worked at Abbott, Analyte Health, Honor, Velano Vascular and 3D Strategy Consulting, where he held roles in engineering, sales, marketing, and general management. He currently resides in San Francisco, CA.  Richard holds a BS in Applied Physics from Emory University and MSME in Bioengineering from Georgia Institute of Technology.
 

Jordan Curnes

Jordan Curnes, MBA

Co-Founder, President and COO

Jordan is a serial entrepreneur with expertise in building companies and recruiting successful management teams to accelerate growth.  Jordan co-founded MicroTransponder in 2007 and has provided leadership during the commercialization process.  Jordan previously worked at Huron Consulting Group where his clients included large healthcare corporations. Jordan holds a finance degree from Notre Dame and an MBA from Duke University.

Bunker Curnes

Bunker Curnes

CFO

Bunker joined MicroTransponder with 15 years of experience in finance and operations roles in various industries. He has worked with MicroTransponder since 2011 in various roles in Finance before eventually taking over as CFO.

Prior to joining MicroTransponder, Bunker worked as the CFO for HEMCO Development, an oil and gas development company. Before HEMCO, Bunker worked as CFO/COO for TEGA Technologies, an early stage tech company focused on digital marketing and communications. And prior to TEGA, Bunker worked at the Boston Consulting Group working in a variety of projects in the healthcare, energy, and retail consumer spaces.

Bunker holds a BS in Mechanical Engineering from the University of Notre Dame and an MBA from the Fuqua School of Business at Duke University.

Brent Tarver

Brent Tarver

Vice President, Clinical Affairs

Brent has 30 years of clinical expertise with vagus nerve stimulation (VNS). He was the third person hired at Cyberonics (now LivaNova) and directed 14 VNS device trials across 11 countries. Brent has been involved in more than 10 neurostimulation IDE submissions, and was very active in providing clinical input for the research program at Cyberonics during his 18-year tenure. Brent led the effort to formulate and successfully complete the pivotal US IDE trial for stroke, VNS-REHAB. Brent holds a degree in electrical engineering from Rice University.

Navzer Engineer

Navzer Engineer, MD, PhD

Co-Founder, Chief Scientific Officer

Navzer has been instrumental in developing the Paired VNS™ technology platform. Navzer’s research in neuroplasticity and VNS laid the foundation of our stroke therapy. He has been the recipient of several grants from the NIH related to the VNS therapy and his research has been published in leading peer-reviewed journals including Nature, and The Lancet.  Navzer completed his medical training in India and then earned a PhD in Neuroscience from the University of Texas at Dallas

Brian Vraciu

Brian Vraciu

Vice President, Marketing

Brian brings over 15 years of marketing, commercialization, and leadership experience.  His recent roles include marketing leadership at Tusker Medical (acquired by Smith+Nephew), Spirox (acquired by Entellus), Entellus Medical (acquired by Stryker), uLab Systems, and Earlens.  Prior to work at these startups, Brian spent over 8 years in various marketing roles with Johnson and Johnson (Acclarent, Lifescan).  Brian received an MBA from Duke University and a BS degree from Indiana University.
 

Klaus Dahmen

Klaus Dahmen

Vice President, Sales

Klaus is a commercial leader with 30 years of sales and marketing experience built upon launching new first-to-market medical devices and successfully scaling commercial organizations.  Klaus has led the pioneering sales efforts and product launches of new treatment therapies within companies including Medtronic, Cyberonics (now LivaNova) and Vertiflex.  Klaus received a degree in business from the University of Wisconsin.
 

Spencer Bailey

Spencer Bailey

Vice President, Market Access & Reimbursement

Spencer is an experienced leader in Market Access and Reimbursement, with nearly 20 years in the healthcare industry.  His breadth of experience in the medical device reimbursement space comes from providing consulting services to 70 medical device clients over 7 years.  Spencer previously worked in hospital and health system administration, overseeing various reimbursement functions of small, mid-sized and large integrated health systems nationwide.  Spencer holds a BS in accounting and MBA from the University of Vermont and is a Certified Professional Coder.
 

Mary Kathryn Williams

Mary Kathryn Williams

Vice President, Commercial Operations & Analytics

Mary Kathryn has over 15 years of medical device experience using innovative thinking and data analysis to optimize performance and support new business development. Prior to working at MicroTransponder, Mary Kathryn held a variety of commercial operations and sales roles at Abbott and Terumo Aortic. She holds a BS in Biology from Washington & Lee University and an MBA from Duke University.

 

Media & Press

Recent news stories and press kit

Learn More

Careers

We are looking to expand our team

Learn More

Request More Info

We look forward to your inquiry

Contact Us